DBG
AGTC

De Burlo Group’s Applied Genetic Technologies Corporation AGTC Stock Holding History

De Burlo Group’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-33,500
Closed -$774K – 108
2014
Q2 		$774K Buy
+33,500
New +$590K 0.18% 70

Other funds holding AGTC

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

De Burlo Group's AGTC Position: Q3 2014 in Review

De Burlo Group sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2014, closing a stake of 33,500 shares — an estimated $774K sold.

De Burlo Group first reported a position in AGTC in Q2 2014 and held it in 1 quarter. The position peaked at $774K in Q2 2014. 42 funds tracked by Wall St. Rank hold AGTC as of Q3 2014.

  • De Burlo Group reported no remaining Applied Genetic Technologies Corporation position as of Q3 2014 after selling out during the quarter.
  • De Burlo Group sold 33,500 Applied Genetic Technologies Corporation shares in Q3 2014, an estimated $774K.
  • De Burlo Group first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 1 quarter.
  • De Burlo Group's Applied Genetic Technologies Corporation position peaked at $774K in Q2 2014.
  • 42 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2014.

Based on De Burlo Group's 13F filing for Q3 2014, filed 7 Nov 2014.